Sinsin Pharmaceutical Co., Ltd (KOSDAQ:002800)

Sinsin Pharmaceutical Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 4, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	80,252	82,376	94,664	84,651	97,850	138,658
Market Cap Growth	-6.37%	-12.98%	11.83%	-13.49%	-29.43%	34.02%
Enterprise Value	122,764	122,361	135,899	130,024	145,574	183,301
Last Close Price	5290.00	5430.00	6170.92	5463.41	6258.03	8867.97
PE Ratio	12.35	16.85	20.23	19.18	-	382.34
PS Ratio	0.73	0.77	0.92	0.92	1.32	2.07
PB Ratio	1.13	1.26	1.53	1.42	1.79	2.47
P/TBV Ratio	1.13	1.26	1.53	1.43	1.80	2.49
P/FCF Ratio	31.75	18.56	-	18.59	-	-
P/OCF Ratio	15.27	13.86	24.09	15.50	4220.66	74.34
EV/Sales Ratio	1.11	1.15	1.33	1.41	1.97	2.73
EV/EBITDA Ratio	9.57	10.97	13.67	14.16	62.51	-
EV/EBIT Ratio	14.27	17.76	22.64	23.96	-	-
EV/FCF Ratio	48.58	27.57	-	28.56	-	-
Debt / Equity Ratio	0.63	0.70	0.72	0.73	0.84	0.81
Debt / EBITDA Ratio	3.47	4.09	4.48	4.73	19.85	-
Debt / FCF Ratio	17.63	10.27	-	9.55	-	-
Asset Turnover	0.83	0.84	0.84	0.78	0.64	0.54
Inventory Turnover	4.07	4.34	4.60	4.98	4.60	3.85
Quick Ratio	0.62	0.56	0.59	0.71	0.76	0.77
Current Ratio	0.95	0.87	0.91	1.06	1.08	1.15
Return on Equity (ROE)	9.54%	7.54%	7.64%	7.62%	-2.61%	0.36%
Return on Assets (ROA)	4.05%	3.39%	3.06%	2.88%	-0.72%	-2.11%
Return on Capital (ROIC)	4.80%	3.96%	3.58%	3.32%	-0.83%	-2.46%
Return on Capital Employed (ROCE)	11.70%	9.80%	8.30%	6.90%	-1.70%	-5.00%
Earnings Yield	8.10%	5.93%	4.94%	5.21%	-1.51%	0.26%
FCF Yield	3.15%	5.39%	-1.14%	5.38%	-2.72%	-7.29%
Dividend Yield	1.13%	1.10%	-	-	-	-
Payout Ratio	14.00%	18.62%	16.21%	-	-	117.13%
Buyback Yield / Dilution	-0.14%	-	-	-	-	-
Total Shareholder Return	1.00%	1.10%	-	-	-	-

Source: S&P Global Market Intelligence. Standard template. Financial Sources.